Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
12/2005
12/13/2005US6974828 3-((2-((3-((Amino(imino)methyl)amino)benzoyl)amino)phenyl)sulf anyl)- 3-(3-pyridinyl)propanoic acid, for example; angiogenic inhibitors; antitumor, -carcinogenic, -metastatic, -diabetic, -arthritic and inflammatory agents; bone disorders
12/13/2005US6974826 such as 3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-methoxybenzylidene-2,4-thiazolidinedione; Hodgkin's disease
12/13/2005US6974825 piperidines or pyrroles with an amido- or sulfonamidophenylamino group; reductive amination of a piperidone with a substituted arylamine then further arylation; ligand for the delta opiod receptor; less side effects than current mu agonists; oral
12/13/2005US6974818 1,2,5-thiadiazol-3-YL-piperazine therapeutic agents useful for treating pain
12/13/2005US6974810 4,5-Dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
12/13/2005US6974809 Inhibitors of interleukin 1-β converting enzyme
12/13/2005US6974808 CRF receptor antagonists and methods relating thereto
12/13/2005US6974792 Alpha 1-antitrypsin preparation as well as a method for producing the same
12/13/2005US6974594 Method of preparing biological materials and preparations produced using same
12/13/2005CA2280151C Arylsulfonyl hydroxamic acid derivatives
12/10/2005CA2507847A1 Prostaglandin reductase
12/10/2005CA2507738A1 Modulation of peroxisome proliferator-activated receptors
12/08/2005WO2005116218A1 Fusion gene of hepatitis b surface antigen with carboxyl end having pres2 immune determinant and the protein thereof
12/08/2005WO2005115993A1 Quinazoline derivative
12/08/2005WO2005115460A1 A method of producing polypeptides from plant protein and use of polypeptides
12/08/2005WO2005115369A2 Use of ppar agonists to treat ruminants
12/08/2005WO2005054432A3 Gene transfer for regulating smooth muscle tone
12/08/2005WO2002066494A3 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade
12/08/2005US20050272936 Imidazolium cxcr3 inhibitors
12/08/2005US20050272931 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272805 Treatment of gastrointestinal disorders with duloxetine
12/08/2005US20050272801 Isoprenoid pathway inhibitors for stimulating cartilage growth
12/08/2005US20050272789 Triazole-derived kinase inhibitors and uses thereof
12/08/2005US20050272783 Amino acids with affinity for the alpha2delta-protein
12/08/2005US20050272774 Substituted cyclohexane derivatives
12/08/2005US20050272764 Imidazopyridine compound
12/08/2005US20050272763 antagonists of the Cannabinoid-1 (CB1) receptor; treating obesity
12/08/2005US20050272761 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
12/08/2005US20050272739 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
12/08/2005US20050272733 1-substituted pyridine-2-ones or 2-substituted pyridazin-3-ones; anticarcinogenic agents for breast and prostate cancer; contraceptives; endometriosis, benign prostatic hypertophy
12/08/2005US20050272718 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
12/08/2005US20050272694 Composition containing beta-glucan and constipation-relieving drug, immunopotentiatior, and skin moistening agent using the composition
12/08/2005US20050272686 Nucleotide based medicament and method of use for treatment of conditions in humans
12/08/2005US20050272676 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
12/08/2005US20050272633 Derivatives of the nf-kappab inducing enzyme, their preparation and use
12/08/2005US20050272077 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
12/08/2005US20050271749 Electrolyte purgative
12/08/2005US20050271743 Treatment of inflammatory skin conditions
12/08/2005US20050271603 Compositions comprising lactoferrin
12/08/2005DE10085485B4 Verfahren zur Detektion des Mutationsgens dspp des hereditären opalisierenden Dentins Method for the detection of the mutation gene DSPP of hereditary opalescent dentin
12/08/2005CA2586222A1 Enzymes for pharmaceutical use
12/08/2005CA2569081A1 Quinazoline derivative
12/08/2005CA2568009A1 Use of ppar agonists to treat ruminants
12/08/2005CA2567398A1 New use
12/07/2005EP1602665A1 Physiologically active peptides and drugs containing the same
12/07/2005EP1602660A1 Aminophosphonic acid derivatives, addition salts thereof and s1p receptor modulators
12/07/2005EP1602658A1 Tricyclic pyrazole derivatives as cannabinoid receptor antagonists
12/07/2005EP1602656A1 Pyrazole derivatives having affinity for cb1 and/or cb2 receptors
12/07/2005EP1602655A1 Benzofuran derivative
12/07/2005EP1602380A1 Preventive/remedy for diseases in upper digestive tract
12/07/2005EP1602379A1 Botulinum toxin B for treating spastic muscle
12/07/2005EP1602377A1 Composition containing beta-glucan and constipation-relieving drug, immunopotentiator and skin moistening agent using the composition
12/07/2005EP1602369A2 Bupropion Metabolites and Methods of their Synthesis and Use
12/07/2005EP1602362A1 Drug composition having active ingredient adhered at high concentration to spherical core
12/07/2005EP1601667A2 Crystalline and amorphous solids of pantoprazole and processes for their preparation
12/07/2005EP1601355A2 Pharmaceutical preparations containing thiazolidinediones for the treatment or prevention of ip-10 mediated diseases
12/07/2005EP1601351A1 Use of ep2 selective receptor agonists in medical treatment
12/07/2005EP1525198B1 Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof
12/07/2005EP1496917B1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders
12/07/2005EP1423409A4 Gastrokines and derived peptides including inhibitors
12/07/2005EP1399438B1 Novel heteroaryl derivatives, their preparation and use
12/07/2005EP1389207B1 Polymorphic and other crystalline forms of cis-ftc
12/07/2005EP1379528A4 Pyrazolopyrimidines as therapeutic agents
12/07/2005EP1353904B1 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
12/07/2005EP1307449B1 1,4-dihydropyridines as bradykinin antagonists
12/07/2005EP1303269B1 Use of 3-substituted oxindole derivatives as kcnq potassium channel modulators
12/07/2005EP1296987B1 Compounds for treating impaired fundic relaxation
12/07/2005EP1294711B1 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases
12/07/2005EP1246828B1 Benzosulfones with calcium antagonist activity
12/07/2005EP1216257B1 Compounds for the treatment of ischemia
12/07/2005EP1216241B1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
12/07/2005EP1178812B1 Methods of making conditioned cell culture medium compositions
12/07/2005EP1171442B1 Xanthine derivatives and analogs as cell signalling inhibitors
12/07/2005EP1147089B1 Phenylphenanthridines with pde-iv inhibiting activity
12/07/2005EP1077928B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005EP1077927B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005EP1073657B1 Imidazo pyridine derivatives which inhibit gastric acid secretion
12/07/2005EP1071412B1 Use of quinolinate for treating gastrointestinal disorders
12/07/2005CN1705479A Distrontium 2-(n,n-di(carboxymethyl)amino)-3-cyano-4-carboxymethyl thiophene-5-carboxylate are used to reduce gastro-duodenal pain
12/07/2005CN1704475A HBsAg fusion gene with carboxyl-end containing pre S2 immune determinant and protein thereof
12/07/2005CN1704404A Tricyclic protein kinase inhibitors
12/07/2005CN1704121A Anti-angiogenic compositions and methods of use
12/07/2005CN1704114A Synergistic antiplaque antigingivitis oral composition
12/07/2005CN1230433C Cyclic AMP-specific phosphodiesterase inhibitors
12/07/2005CN1230431C Arylmethylamine derivatives for use as tryptase inhibitors
12/07/2005CN1230202C External coated chewing gum products
12/07/2005CN1230198C Combination therapy comprising ribavirin and interferon alpha in antiviral treatment naive patients having G chronic hepatitis C infection
12/07/2005CN1230195C Oral preparation containing seaweed for reduction of plaque and calculus
12/07/2005CN1230193C Water-purging pill
12/07/2005CN1230189C Health-care medicinal liquor
12/07/2005CN1230187C 'Ganfukang' for treating hepatism
12/07/2005CN1230183C Dictyoptera grease prepared healthcare food
12/07/2005CN1230166C Gyrase inhibitors and uses thereof
12/07/2005CN1230158C Mixture of primary fatty acids obtained from sugar can wax and pharmaceutical use thereof
12/07/2005CN1230156C Fibrauretine dispersant tablet and its preparing method
12/07/2005CN1230093C Yeast protein composition for promoting digestion and assimilation by ruminants, and its prepn. method
12/06/2005US6972321 Monomeric protein of the TGF-β family
12/06/2005US6972299 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
12/06/2005US6972296 Antichoelsterol agents; cardiovascular disorders; antihistamines; multiple sclerosis; antihistamines
12/06/2005US6972295 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis
1 ... 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 ... 1258